" class="no-js "lang="en-US"> Diseases Archives - Medtech Alert
Saturday, April 01, 2023

Sort by:


Top Post

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit […]

NADclinic Group, BioStarks and Do Not Age Announce Exclusive Partnership to Revolutionise Personalised Longevity

NADclinic Group, BioStarks and Do Not Age have joined forces in an exclusive partnership to […]

PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial

PathAI, a leading provider of AI-powered pathology, today announced its partnership with GSK on HORIZON, […]

Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision […]

Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases

Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]

Implantica Launches RefluxStop™ in Italy

Implantica, a medtech company at the forefront of bringing advanced technology into the body, announces […]

Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases

Granular Therapeutics, a private biotech company specialising in precision biologic therapies for treating mast cell […]

AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson's Disease

Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary […]

New Imaging Method for Evaluating Transport of Oxygen to Blood Cells

In cooperation with Perimed AB, researchers from the Department of Biomedical Engineering at Linköping University, […]

Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform

Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced it has […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more